Voyageur Pharmaceuticals Stock Market Value
| VM Stock | CAD 0.18 0.01 5.88% |
| Symbol | Voyageur |
Voyageur Pharmaceuticals Price To Book Ratio
Voyageur Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Voyageur Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Voyageur Pharmaceuticals.
| 12/14/2025 |
| 01/13/2026 |
If you would invest 0.00 in Voyageur Pharmaceuticals on December 14, 2025 and sell it all today you would earn a total of 0.00 from holding Voyageur Pharmaceuticals or generate 0.0% return on investment in Voyageur Pharmaceuticals over 30 days. Voyageur Pharmaceuticals is related to or competes with Avicanna, Charlottes Web, Briacell Therapeutics, Perimeter Medical, and Rubicon Organics. Voyageur Minerals Ltd., an exploration stage company, engages in acquiring, exploring, and developing mineral exploratio... More
Voyageur Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Voyageur Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Voyageur Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.59 | |||
| Information Ratio | 0.0599 | |||
| Maximum Drawdown | 28.17 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 7.14 |
Voyageur Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Voyageur Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Voyageur Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Voyageur Pharmaceuticals historical prices to predict the future Voyageur Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0667 | |||
| Jensen Alpha | 0.3362 | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | 0.0372 | |||
| Treynor Ratio | 0.503 |
Voyageur Pharmaceuticals Backtested Returns
Voyageur Pharmaceuticals appears to be out of control, given 3 months investment horizon. Voyageur Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.1, which indicates the firm had a 0.1 % return per unit of risk over the last 3 months. By inspecting Voyageur Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.55% is justified by implied risk. Please review Voyageur Pharmaceuticals' Risk Adjusted Performance of 0.0667, coefficient of variation of 1281.14, and Semi Deviation of 4.02 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Voyageur Pharmaceuticals holds a performance score of 8. The entity has a beta of 0.81, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Voyageur Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Voyageur Pharmaceuticals is expected to be smaller as well. Please check Voyageur Pharmaceuticals' semi variance, as well as the relationship between the accumulation distribution and day typical price , to make a quick decision on whether Voyageur Pharmaceuticals' existing price patterns will revert.
Auto-correlation | 0.75 |
Good predictability
Voyageur Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Voyageur Pharmaceuticals time series from 14th of December 2025 to 29th of December 2025 and 29th of December 2025 to 13th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Voyageur Pharmaceuticals price movement. The serial correlation of 0.75 indicates that around 75.0% of current Voyageur Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.75 | |
| Spearman Rank Test | 0.85 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Voyageur Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Voyageur Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Voyageur Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Voyageur Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Voyageur Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Voyageur Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Voyageur Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Voyageur Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Voyageur Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Voyageur Pharmaceuticals Lagged Returns
When evaluating Voyageur Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Voyageur Pharmaceuticals stock have on its future price. Voyageur Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Voyageur Pharmaceuticals autocorrelation shows the relationship between Voyageur Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Voyageur Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Voyageur Stock Analysis
When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.